Search

Your search keyword '"Clendenning, Mark"' showing total 459 results

Search Constraints

Start Over You searched for: Author "Clendenning, Mark" Remove constraint Author: "Clendenning, Mark"
459 results on '"Clendenning, Mark"'

Search Results

1. Intratumoral presence of the genotoxic gut bacteria pks+E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer

3. A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report

4. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome

5. Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer

7. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures

8. Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control study

9. Evaluating Multiple Next-Generation Sequencing–Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status

10. Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer

12. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

13. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family

14. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands

16. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome

17. Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

18. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers

19. Intratumoral presence of the genotoxic gut bacteria pks+E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer.

20. A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report

23. Supplemental Table 1 from Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History

24. Supplementary Data from Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

25. Supplementary Tables from SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer

26. Supplementary Figures from SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer

27. Data from Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

28. Data from Lynch Syndrome–Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

29. Supplementary Tables from Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing

30. Appendix - clean version from Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

31. Supplementary Figure 1 from Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing

32. Supplementary Tables from Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

33. Supplementary Figure 2 from Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing

34. Description of supplementary files from Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing

35. Supplementary Methods from SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer

36. Supplementary Table 1 from Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients

37. Supplementary Table 2 from Origins and Prevalence of the American Founder Mutation of MSH2

38. Supplementary Figure 1 from Origins and Prevalence of the American Founder Mutation of MSH2

39. Supplementary Table 1 from Origins and Prevalence of the American Founder Mutation of MSH2

40. Data from Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients

41. Supplementary Table 2 from Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients

42. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

43. Evaluating Multiple Next-Generation Sequencing–Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status

44. Additional file 1 of A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome

45. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas

48. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype

49. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype

50. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene

Catalog

Books, media, physical & digital resources